Literature DB >> 20054269

National and surgical health care expenditures, 2005-2025.

Eric Muñoz1, William Muñoz, Leslie Wise.   

Abstract

OBJECTIVE AND
BACKGROUND: Health care expenditures for 2005 in the United States were $1.9733 trillion and 15.9% of the gross domestic product (GDP). Twenty-nine percent of those expenditures were secondary to surgical revenues. Health care expenditures are increasing 2(1/2) times the rate of the general US economy and are being fed by new technologies, new medications, the aging population, more services provided per patient, defensive medicine and little tort reform, the insurance system, and the free rider problem, ie, patients are cared for as emergencies regardless of insurance coverage and legality, which all have contributed to rising health care and surgical expenditures over the last 50 years.
METHODS: The purpose of this study was to project aggregate national health care expenditures, aggregate surgical health care expenditures, and the United States GDP for the years 2005-2025. Model building and existing state and national data were used. Aggregate surgical health care expenditures were computed as 29% of aggregate health care expenditures using a unique model developed by the late Dr. Francis D. Moore. The model of Dr. Moore which used 1981 federal data was verified/tested using data from UMDNJ-University Hospital, and New Jersey and national data from 2005. From 1965 to 2005 mean health care expenditures increased at 4.9% per year, and US GDP increased at a mean of 2.1% per year.
RESULTS: Aggregate surgical expenditures are expected to grow from $572 billion in 2005 (4.6% of US GDP) to $912 billion (2005 dollars) in the year 2025 (7.3% of US GDP). Aggregate health care expenditures are projected to increase from $5572 per capita (15.9% of GDP) in 2005 to $8832 per capita (2005 dollars) in 2025 (25.2% of US GDP). Both surgery and national health care expenditures are expected to expand by almost 60% during the period 2005-2025. Thus, surgical health care expenditures by 2025 are likely to be 1/14 of the US economy, and health care expenditures will be (1/4) of the US economy.
CONCLUSIONS: Real per capita GDP growth is relatively flat in the United States. Rising surgical health care expenditures and national health care expenditures are a significant issue for the US population. Unfortunately, programs at the state and federal level as well as private programs, for the last 50 years have not been able to slow the growth in health care expenditures. These trends are likely to continue and the effects will be: * A change in the US standard of living as surgical and health care expenditures become a larger part of the earned dollar per American especially with the current volatility of the US economy, * A rise in the cost of products made in the United States to pay the rising health care bill with a concomitant change in our national and international standard of living, and * An increasing debt and increases in federal and state taxes which will be required to maintain the current health care system, ie, Medicare, Medicaid, and the private health care insurance payment scheme, which has not changed substantially over the past 40 to 50 years. Surgeons must look at the incremental benefit of new technologies and procedures and determine which to choose if we are to slow the growth of surgical health care expenditures.

Entities:  

Mesh:

Year:  2010        PMID: 20054269     DOI: 10.1097/SLA.0b013e3181cbcc9a

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

1.  Effectiveness of a surgical glove port for single port surgery.

Authors:  Michihiro Hayashi; Mitsuhiro Asakuma; Koji Komeda; Yoshiharu Miyamoto; Fumitoshi Hirokawa; Nobuhiko Tanigawa
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 2.  Surgical research using national databases.

Authors:  Ram K Alluri; Hyuma Leland; Nathanael Heckmann
Journal:  Ann Transl Med       Date:  2016-10

3.  Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre.

Authors:  Swapnil D Kachare; Kendall R Liner; Nasreen A Vohra; Emmanuel E Zervos; Todd Hickey; Timothy L Fitzgerald
Journal:  HPB (Oxford)       Date:  2014-10-09       Impact factor: 3.647

4.  Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database.

Authors:  Sara Poston; Michael S Broder; Melinda Maggard Gibbons; Robert Maclaren; Eunice Chang; Christine J Vandepol; Suzanne F Cook; Lee Techner
Journal:  P T       Date:  2011-04

5.  Probabilistic forecasting of surgical case duration using machine learning: model development and validation.

Authors:  York Jiao; Anshuman Sharma; Arbi Ben Abdallah; Thomas M Maddox; Thomas Kannampallil
Journal:  J Am Med Inform Assoc       Date:  2020-12-09       Impact factor: 4.497

6.  Understanding Costs of Care in the Operating Room.

Authors:  Christopher P Childers; Melinda Maggard-Gibbons
Journal:  JAMA Surg       Date:  2018-04-18       Impact factor: 14.766

Review 7.  Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition.

Authors:  Rohan Shah; Adrian Diaz; Marzia Tripepi; Fabio Bagante; Diamantis I Tsilimigras; Nikolaos Machairas; Fragiska Sigala; Dimitrios Moris; Savio George Barreto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.452

8.  Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument.

Authors:  Jeffrey M Sutton; Gregory C Wilson; Ian M Paquette; Koffi Wima; Dennis J Hanseman; R Cutler Quillin; Jeffrey J Sussman; Michael J Edwards; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

9.  Early Impact of Medicare Accountable Care Organizations on Inpatient Surgical Spending.

Authors:  Hari Nathan; Jyothi R Thumma; Andrew M Ryan; Justin B Dimick
Journal:  Ann Surg       Date:  2019-02       Impact factor: 12.969

10.  Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases.

Authors:  Daniel E Abbott; Scott B Cantor; Chung-Yuan Hu; Thomas A Aloia; Y Nancy You; Sa Nguyen; George J Chang
Journal:  J Am Coll Surg       Date:  2012-05-04       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.